by Frank Sorce | Feb 1, 2022 | Press Releases
Boston, MA (February 1, 2022) – Syner-G BioPharma Group (“Syner-G” or the “Company”), a leading provider of Chemistry, Manufacturing, and Controls (“CMC”) technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology...
by Frank Sorce | Jan 10, 2022 | Blog, Regulatory Affairs
January 10, 2022 | Julia DiFiore, PhD | Clinical Research Scientist Many of us involved with drug development derive a lot of satisfaction in knowing that our work contributes to improving the health of patients around the globe. As professional drug development...
by Frank Sorce | Nov 16, 2021 | Press Releases
Research Triangle Park, NC—November 15, 2021 – In a virtual gathering, Impact Pharmaceutical Services, Inc. (IMPACT) (now Syner-G BioPharma Group) team members opened boxes specially curated to evoke the trust and mutual respect that has grown out of our relationships...
by Frank Sorce | Oct 6, 2021 | Press Releases
– New brand reflects the company’s evolution to support market dynamics – Company provides more than traditional consulting services – Solutions to Chemistry, Manufacturing, & Controls challenges remains paramount Southborough, MA, October 6,...
by Frank Sorce | Sep 10, 2021 | Press Releases
RESEARCH TRIANGLE PARK, NC: 30 August 2021 – In the first half of 2021, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. As we all continued to work from home, our virtual...